Pre-therapeutic Validation of the Virtual Reality-based Exposure Scenario for CBT "ReVBED" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder (BED) (RevBED)

Pre-therapeutic Validation of the VR-based Exposure Scenario for CBT "ReVBEB" for the Induction of Food Craving in Patients With Bulimia and Binge Eating Disorder

Food craving is a major therapeutic issue in Eating Disorders with binge eating: the Bulimia Nervosa and the Binge Eating Disorder (BED). Food craving is linked to compulsive eating and its apprehension is currently based on classic Cognitive and Behavioural Therapies (CBT). However, it remains difficult to induce in therapy and a significant number of patients do not respond to classic CBTs. The development of exposure scenarios for CBT in virtual reality (VR) has allowed a gain in efficacy and in particular therapeutic effects lasting longer after treatment. Nevertheless, the stimuli used are often simple food visuals and insufficiently consider the many factors influencing food craving (physical, psychological, socio-environmental...) and VR immersion is still limited by the use of 3D laptops (fixed) rather than wireless headsets.

Study Overview

Detailed Description

Eating Disorders-specialized clinicians from Saint-Etienne University Hospital Center (CHU) and VR-specialized engineers from National School of Engineering of Saint-Etienne (ENISE) therefore collaborated in the creation of ReVBED, a VR-based exposure scenario for CBT for the induction of food craving in eating disorders with binge eating. ReVBED offers successive exposures to multimodal stimuli in a coherent scenario and in an immersive virtual environment via a wireless VR headset.

Our first objective is to validate the effectiveness of our scenario in inducing food craving in patients with bulimia and BED.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Saint-Etienne, France
        • Recruiting
        • CHU Saint-Etienne
        • Sub-Investigator:
          • Baptiste RAVEY, MD
        • Principal Investigator:
          • Aurélia GAY, MD
        • Sub-Investigator:
          • Catherine MASSOUBRE, MD PhD
        • Sub-Investigator:
          • Vikesh BHOOWABUL, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients: who meet Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for Bulimia Nervosa or Binge Eating Disorder
  • Controls: paired to patients on age and level of education

Exclusion Criteria:

  • Patients and controls:
  • Under legal protection measure (guardianship, curatorship or safeguard of justice)
  • Having a treatment being established and / or not stabilized (declarative) able to alter the physiological data recorded and the answers to the self-questionnaires
  • Having one or more sensory deficit(s) or disorder(s) incompatible with the use of VR equipment (declarative)
  • Patients: who have already benefited from specific care targeting food craving (declarative) Controls: with a score greater than or equal to 88 on the Bulimia Test (BULIT)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: patients with bulimia or binge eating disorder

ReVBED is a VR-based exposure scenario for CBT for the induction of food craving in patients with bulimia nervosa and binge eating disorder.

The use of ReVBED requires no VR experience and only generic and commonly used virtual reality tools (a computer with VR software, a wireless virtual reality headset, two controllers and headphones), all with a CE mark, allowing its users to move in and interact with a specially designed virtual environment.

This exhibit scenario takes place in a VR environment built to represent a standard apartment consisting of four exhibit rooms (a bedroom, a teenager's bedroom, a living room and a kitchen) in which the ReVBED user moves sequentially through the scenario. In each room, specific cues of craving are displayed. These cues are not only visual, but also audio, emotional and socio-environmental. A central hall connects the other rooms and serves as a safe place for debriefing, where measures such as craving are assessed.

Other Names:
  • the use of the scenario in VR
Other: control
paired healthy controls

ReVBED is a VR-based exposure scenario for CBT for the induction of food craving in patients with bulimia nervosa and binge eating disorder.

The use of ReVBED requires no VR experience and only generic and commonly used virtual reality tools (a computer with VR software, a wireless virtual reality headset, two controllers and headphones), all with a CE mark, allowing its users to move in and interact with a specially designed virtual environment.

This exhibit scenario takes place in a VR environment built to represent a standard apartment consisting of four exhibit rooms (a bedroom, a teenager's bedroom, a living room and a kitchen) in which the ReVBED user moves sequentially through the scenario. In each room, specific cues of craving are displayed. These cues are not only visual, but also audio, emotional and socio-environmental. A central hall connects the other rooms and serves as a safe place for debriefing, where measures such as craving are assessed.

Other Names:
  • the use of the scenario in VR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Verbal Rating Scales of food craving (VRS)
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Evaluate variation in food craving assessed by Verbal Rating Scales (VRS) : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
Change from the first exploration of virtual rooms to the last exploration (20 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Verbal Rating Scales of food craving (VRS)
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Evaluate variation in food craving assessed by Verbal Rating Scales (VRS : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
Change from the start of exploration of each virtual rooms to the end (5 minutes)
Heart rate variation
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Measurement of cyclical fluctuations with sensor
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Pupillometry
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 min)
Measurement of phase fluctuations of pupil diameters with visual sensor
Change from the first exploration of virtual rooms to the last exploration (20 min)
Electro-Dermal Activity
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Measurement of skin conductance fluctuations by amplifying the potential differences between two electrodes in contact with the subject's skin
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Heart rate variation
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Measurement of cyclical fluctuations with sensor
Change from the start of exploration of each virtual rooms to the end (5 minutes)
Pupillometry
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Measurement of phase fluctuations of pupil diameters with visual sensor
Change from the start of exploration of each virtual rooms to the end (5 minutes)
Electro-Dermal Activity
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Measurement of skin conductance fluctuations by amplifying the potential differences between two electrodes in contact with the subject's skin
Change from the start of exploration of each virtual rooms to the end (5 minutes)
Variations of the measurements VRS of the food craving and each of the physiological measurements of the food craving
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Correlation between the variations of the VRS measurements and each of the physiological measurements (HRV, pupillometry and EDA) of the food craving induced in patients with bulimia and BED, compared to matched healthy controls.
Change from the start of exploration of each virtual rooms to the end (5 minutes)
Verbal Rating Scales of anxiety (VRS)
Time Frame: Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Evaluate variation of anxiety assessed by Verbal Rating Scales (VRS : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
Change from the first exploration of virtual rooms to the last exploration (20 minutes)
Verbal Rating Scales of anxiety (VRS)
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Evaluate variation of anxiety assessed by Verbal Rating Scales (VRS) : self-assessment from 0 to 10 with 0 = "no food craving felt" and 10 = "maximum food craving felt")
Change from the start of exploration of each virtual rooms to the end (5 minutes)
Variations of the VRS food craving and of the VRS anxiety of the food craving
Time Frame: Change from the start of exploration of each virtual rooms to the end (5 minutes)
Correlation between the variations Food Craving Verbal Rating Scales and Anxiety Verbal Rating Scales (VRS : self-assessment from 0 to 10 with 0 = "no felt" and 10 = "maximum felt") the VRS food craving and VRS anxiety
Change from the start of exploration of each virtual rooms to the end (5 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aurélia GAY, MD, CHU DE SAINT-ETIENNE

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

May 2, 2022

First Submitted That Met QC Criteria

May 18, 2022

First Posted (Actual)

May 23, 2022

Study Record Updates

Last Update Posted (Estimated)

November 16, 2023

Last Update Submitted That Met QC Criteria

November 14, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Binge-Eating Disorder

Clinical Trials on experimentation of the virtual reality "RevBED"

3
Subscribe